{"id":"https://openalex.org/W4379340429","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e20055","title":"Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience.","display_name":"Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379340429","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e20055"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.e20055","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e20055","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e20055","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005275342","display_name":"Filip Ionescu","orcid":"https://orcid.org/0000-0003-3097-8985","observed_orcids":["https://orcid.org/0000-0003-3097-8985"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Filip Ionescu","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040819542","display_name":"Parth C. Patel","orcid":"https://orcid.org/0000-0002-8528-1029","observed_orcids":["https://orcid.org/0000-0002-8528-1029","https://orcid.org/0009-0004-5481-5464"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Parth Patel","raw_affiliation_strings":["University of South Florida, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of South Florida, Tampa, FL","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071309028","display_name":"Shrinjaya B Thapa","orcid":"https://orcid.org/0009-0006-1202-9064","observed_orcids":["https://orcid.org/0009-0006-1202-9064"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shrinjaya Thapa","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082454000","display_name":"Dimitrios Drekolias","orcid":"https://orcid.org/0000-0001-5905-4167","observed_orcids":["https://orcid.org/0000-0001-5905-4167"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimitrios Drekolias","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087190330","display_name":"Brandon Jamaal Blue","orcid":"https://orcid.org/0000-0003-0639-3768","observed_orcids":["https://orcid.org/0000-0003-0639-3768"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Jamaal Blue","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047518602","display_name":"Omar Alexis Castaneda Puglianini","orcid":"https://orcid.org/0000-0003-0423-5870","observed_orcids":["https://orcid.org/0000-0003-0423-5870"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omar Alexis Castaneda Puglianini","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091150651","display_name":"Jose Leonel Ochoa-Bayona","orcid":"https://orcid.org/0009-0004-7587-2214","observed_orcids":["https://orcid.org/0009-0004-7587-2214"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose L. Ochoa-Bayona","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062342454","display_name":"Ciara Louise L. Freeman","orcid":"https://orcid.org/0000-0002-0662-6480","observed_orcids":["https://orcid.org/0000-0002-0662-6480"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ciara L. Freeman","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055261814","display_name":"Hien D. Liu","orcid":"https://orcid.org/0000-0002-9945-4381","observed_orcids":["https://orcid.org/0000-0002-9945-4381"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hien Liu","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047819225","display_name":"Doris K. Hansen","orcid":"https://orcid.org/0000-0002-9813-3578","observed_orcids":["https://orcid.org/0000-0002-9813-3578"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doris K. Hansen","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062691289","display_name":"Taiga Nishihori","orcid":"https://orcid.org/0000-0002-2621-7924","observed_orcids":["https://orcid.org/0000-0002-2621-7924"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taiga Nishihori","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074346739","display_name":"Ariosto Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ariosto Silva","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012307401","display_name":"Praneeth Reddy Sudalagunta","orcid":"https://orcid.org/0000-0003-1283-9332","observed_orcids":["https://orcid.org/0000-0003-1283-9332"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Praneeth Reddy Sudalagunta","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064581434","display_name":"Jason B. Brayer","orcid":"https://orcid.org/0000-0003-1126-2279","observed_orcids":["https://orcid.org/0000-0003-1126-2279"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason B. Brayer","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087799564","display_name":"Melissa Alsina","orcid":"https://orcid.org/0000-0003-4946-823X","observed_orcids":["https://orcid.org/0000-0003-4946-823X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Alsina","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077110117","display_name":"Rachid Baz","orcid":"https://orcid.org/0000-0003-4538-4733","observed_orcids":["https://orcid.org/0000-0003-4538-4733"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachid C. Baz","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082565225","display_name":"Ariel Felipe Grajales-Cruz","orcid":"https://orcid.org/0000-0003-0999-1771","observed_orcids":["https://orcid.org/0000-0003-0999-1771"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ariel Felipe Grajales-Cruz","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"e20055","last_page":"e20055"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9440000057220459},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.984000027179718},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9449999928474426},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8640000224113464},{"id":"https://openalex.org/keywords/anti-cd38-monoclonal-antibody","display_name":"anti-CD38 monoclonal antibody","score":0.8299999833106995},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9520000219345093},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.5270000100135803},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.4569999873638153},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.4000000059604645},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6700000166893005},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8633467555046082},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.7621983885765076},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.6707214117050171},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.6501590609550476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6120601296424866},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5018789768218994},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49669820070266724},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.48519375920295715},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4795515239238739},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4658084511756897},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.4492543637752533},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4391189515590668},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4280979633331299},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3787961006164551},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37186676263809204},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.33942145109176636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21567192673683167},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.1941680610179901},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.18922650814056396},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.15213912725448608},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.e20055","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e20055","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e20055","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405039604","https://openalex.org/W4405038428","https://openalex.org/W3168449182","https://openalex.org/W4205158786","https://openalex.org/W3107777078","https://openalex.org/W3114816661","https://openalex.org/W4389228859","https://openalex.org/W3213225682","https://openalex.org/W4405054914","https://openalex.org/W2790174510"],"abstract_inverted_index":{"e20055":[0],"Background:":[1],"The":[2,121,153,432],"BCL-2":[3],"inhibitor":[4,224,386],"venetoclax":[5],"(Ven)":[6],"has":[7],"shown":[8],"activity":[9],"in":[10,24,35,92,162,201,207,216,251,260,269],"MM":[11,26,94,112,131,156,178,421],"with":[12,40,218,312,325,332,351,423,426],"t(11;14).":[13],"However,":[14],"a":[15,49,241,313],"randomized":[16,57],"trial":[17],"comparing":[18],"bortezomib":[19],"and":[20,95,99,104,137,150,171,213,235,306,443],"dexamethasone":[21],"\u00b1":[22],"Ven":[23,41,60,198,253,271,309,435],"unselected":[25],"patients":[27,113,136,179,203,227,249,422],"was":[28,124,160,184,199,267,310,337,349,373,397],"notable":[29],"for":[30,166,293],"decreased":[31],"overall":[32],"survival":[33,46],"(OS)":[34],"the":[36,59,86,128,208,252,261,270,440],"non-t(11;14)":[37],"population":[38],"treated":[39,114,425],"despite":[42],"improved":[43],"progression":[44],"free":[45],"(PFS).":[47],"In":[48,289,344,416],"subgroup":[50],"analysis":[51,291],"of":[52,89,130,155,244,298,316],"35":[53],"t(11;14)":[54,93,111,424],"patients,":[55],"those":[56,138],"to":[58,84,96,164,257,384,413,434],"arm":[61],"had":[62],"superior":[63,430],"OS":[64,125,266],"(HR,":[65,318],"0.61":[66],"[95%":[67,275,282,356,363,379,390],"CI,":[68,276,283,321,341,357,364,380,391],"0.16-2.32])":[69],"but":[70,394],"this":[71,395,417],"did":[72,140],"not":[73,141,398],"reach":[74],"statistical":[75],"significance":[76],"(Kumar":[77],"et":[78],"al,":[79],"Blood":[80],"2021).":[81],"We":[82,107],"sought":[83],"investigate":[85],"real-world":[87],"impact":[88],"Ven-based":[90,333,427],"therapy":[91],"explore":[97],"patient":[98],"disease-related":[100],"factors":[101],"impacting":[102],"response":[103,327,433],"durability.":[105],"Methods:":[106],"retrospectively":[108],"identified":[109],"all":[110],"at":[115,231],"Moffitt":[116],"Cancer":[117],"Center":[118],"between":[119,134],"2000-2022.":[120],"primary":[122],"endpoint":[123],"measured":[126],"from":[127],"time":[129,297],"diagnosis":[132,157],"compared":[133,256,383],"Ven-treated":[135],"who":[139],"receive":[142],"Ven.":[143,414],"Secondary":[144],"endpoints":[145],"were":[146,174,180,193,196,410],"\u2265VGPR":[147,331],"rate,":[148],"PFS,":[149],"key":[151],"toxicities.":[152],"era":[154],"(5-year":[158],"intervals)":[159],"included":[161],"analyses":[163],"account":[165],"novel":[167],"therapies.":[168],"Kaplan-Meier":[169],"estimates":[170],"Cox":[172],"regression":[173],"employed.":[175],"Results:":[176],"262":[177],"included.":[181],"Median":[182,264,335,371],"age":[183],"64":[185],"years":[186],"(interquartile":[187],"range":[188],"[IQR],":[189],"56-71":[190],"years);":[191],"61%":[192],"male;":[194],"87%":[195],"White.":[197],"used":[200],"78":[202],"(30%)":[204],"on":[205],"median":[206,242],"5th":[209],"line":[210],"(IQR,":[211],"4-7)":[212],"most":[214],"commonly":[215],"combination":[217],"anti-CD38":[219,375],"antibodies":[220],"(42%)":[221],"or":[222,408],"proteasome":[223,385],"(32%).":[225],"Most":[226],"(77%)":[228],"initiated":[229],"treatment":[230],"400":[232],"mg":[233],"daily":[234],"25%":[236],"required":[237],"dose":[238],"reduction.":[239],"At":[240],"follow-up":[243],"52":[245],"months,":[246],"18":[247],"(23%)":[248],"died":[250],"group":[254,272],"as":[255],"87":[258],"(47%)":[259],"non-Ven":[262],"group.":[263],"unadjusted":[265],"longer":[268,374],"(206":[273],"months":[274,281,339,355,362,378,389],"112-249":[277],"months]":[278],"vs":[279,360],"75":[280],"65-97":[284],"months];":[285],"p":[286,368],"<":[287],"0.01).":[288],"multivariable":[290],"accounting":[292],"demographics,":[294],"high-risk":[295],"cytogenetics,":[296],"diagnosis,":[299],"penta-exposed":[300],"status,":[301],"autologous":[302],"stem":[303],"cell":[304],"transplant":[305],"BCMA-directed":[307],"therapy,":[308],"associated":[311,350],"reduced":[314],"risk":[315],"death":[317],"0.26;":[319],"95%":[320],"0.15-0.47).":[322],"Of":[323],"73/78":[324],"available":[326],"data,":[328],"38%":[329],"achieved":[330],"therapy.":[334],"PFS":[336,353,372],"27":[338],"(95%":[340],"13-39":[342],"months).":[343],"univariable":[345],"analyses,":[346],"1q":[347],"amplification/gain":[348],"inferior":[352],"(13":[354],"6.5-28":[358],"months])":[359],"33":[361],"23":[365],"months-not":[366],"reached/NR];":[367],"=":[369,402],"0.04).":[370],"antibody":[376],"(33":[377],"13":[381],"months-NR])":[382],"combinations":[387,428],"(11":[388],"7":[392],"months-NR]),":[393],"difference":[396],"statistically":[399],"significant":[400],"(p":[401],"0.1).":[403],"No":[404],"grade":[405],"3/4":[406],"infections":[407],"deaths":[409],"directly":[411],"attributable":[412],"Conclusions:":[415],"real":[418],"world":[419],"dataset,":[420],"exhibited":[429],"survival.":[431],"may":[436],"be":[437],"impacted":[438],"by":[439],"partner":[441],"agent":[442],"concurrent":[444],"cytogenetic":[445],"abnormalities.":[446]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2023-06-05T00:00:00"}